Platform Network Status: Normal Service
GMT: --:--:--
CRMNET
← Back to Dispatch Log
Forecasting 2026-08-11 4 min read

4 Common Sales Pipeline Forecasting Mistakes

DISPATCH BY: The CRMnet Team

Forecasts get built with good intentions and fall apart in the same predictable ways. Here are the mistakes that show up most often in B2B sales pipelines, and simple ways to catch them before they distort a quarter's numbers.

1. Stale Close Dates

A close date set six weeks ago and never revisited is a guess wearing a forecast's clothing. If a deal's close date has slipped twice without a corresponding change in stage or next step, that's a signal worth surfacing, not ignoring.

2. Stage Inflation

Deals get pushed to "Proposal" or "Negotiation" earlier than they should, often to make a rep's pipeline look healthier in a stand-up meeting. Over time, this quietly erodes trust in the stage labels themselves. A useful check: does every deal in a stage have the artifact that stage implies (an actual proposal document, a signed NDA)? If not, it's not really in that stage.

3. Single-Threaded Deals

A deal with one contact and no visibility into the buying committee is fragile. If that contact changes roles or goes quiet, the deal often dies without anyone noticing why. Tracking how many stakeholders are engaged per deal is a better leading indicator than deal value alone.

4. Ignoring Velocity

Total pipeline value tells you less than how fast deals typically move through each stage. A pipeline that's growing in size but slowing in velocity is often masking a problem — usually somewhere in qualification or proposal follow-up.

The Fix Is Usually Cadence, Not Software

Most forecasting problems aren't solved by a new tool — they're solved by a weekly habit of actually reviewing stale deals and asking hard questions about what's really happening, rather than trusting whatever the dashboard shows by default.

Building CRMnet in Public

Join the waitlist to get updates as we build a UK CRM designed around timetabled, predictable revenue.

Join the Waitlist →